“Identifying Cancer Patients at High Risk for ER Visits and Hospitalizations: The Supportive Oncology Screener” and “Acute Promyelocytic Leukemia: Induction Therapy for the High Risk Patient” |
10/16/2017 - 12:00pm to 1:00pm |
“Cancer Risk Clinic & Center for Clinical Cancer Genetics Program Update |
10/23/2017 - 12:00pm to 1:00pm |
The Microbiome and Anticancer Immunosurveillance |
10/30/2017 - 12:00pm to 1:00pm |
“Understanding Normal and Malignant Hematopoiesis One Cell At a Time” |
11/06/2017 - 12:00pm to 1:00pm |
“Using the Genome to Achieve Precision Medicine” |
11/13/2017 - 12:00pm to 1:00pm |
“The Expanding Role of Germline Genetics in Cancer” |
11/20/2017 - 12:00pm to 1:00pm |
“BRAF Mutation in Colorectal Cancer” and “Targeting DNA Repair Pathways in Mesothelioma” |
11/27/2017 - 12:00pm to 1:00pm |
Innovations in Global Oncology Clinical Trials |
12/04/2017 - 12:00pm to 1:00pm |
“Neoadjuvant Pembrolizumab in Resectable Early Stage Gastroesophageal Adenocarcinoma” and “Overcoming Oncogene-Mediated Immune Exclusion to Improve Immunotherapy Responsiveness” |
12/18/2017 - 12:00pm to 1:00pm |
Optimizing the Recognition, Surveillance, and Therapy of Patients with Hereditary Hematopoietic Disorders |
01/08/2018 - 12:00pm to 1:00pm |